Clinical Trial Update: Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing T cell depletion to improve transplant outcomes in adults with acute myeloid leukemia has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Leukemia, Myelocytic, Acute | Phase 2 | Status: COMPLETED | Results posted: 2014-11-10